healthgevity bpc 157 + PEA 500 Capsules – Alive and Well Shop Regeneration or Risk? A Narrative

A Pharmacy Compounding Advisory Committee meeting on July 2324, 2026 will evaluate whether TB-500 should be formally added to the authorized bulk-substances list compounding pharmacies can use

Issues such as small sample sizes, lack of control groups, and short follow-up periods further weaken the validity of these studies

This information helps inform decisions about continued use and identifies any concerning trends early

Check the pen label and liquid, attach a sterile needle, set the prescribed dose, and choose an approved injection site

Approved for Use with Health Savings Accounts (HSA) and Flex Savings Accounts (FSA)

If the desired results are not seen after 3-6 months, or if the patient cannot tolerate the medication, discontinuation or alternative treatments may be considered